The Asia Pacific Narcolepsy Therapeutics Market would witness market growth of 11.4% CAGR during the forecast period (2022-2028).
Narcoleptics have a strong want to sleep and are low on energy. Cataplexy is an abrupt loss of muscle tone and weakness that might last for a few seconds or several minutes. It frequently happens when under the stress of weariness; it is brought on by feelings like fear, laughing, or surprise. Temporarily being unable to move any portion of the body is the hallmark of sleep paralysis. Fear sets it off, but it has no negative effects. Narcoleptics may also hallucinate, which are characterized by vivid, frequently terrifying dreams.
Any mental disorder, a deficiency in the brain chemical hypocretin, hereditary conditions, infections, trauma, hormonal changes, stress, immune-system failure, etc. can all contribute to narcolepsy. A hereditary predisposition exists in around 10% of people who develop narcolepsy with cataplexy. Men and women of any age can develop narcolepsy, which can start in the early 20s and last the rest of their lives. In the United States, it is estimated that one person in every 2000 individuals has narcolepsy, and those who have it live regular lives.
It was conducted in the family medicine outpatient department at St. Philomena's Hospital, Bengaluru, as part of a cross-sectional study. Written consent was obtained from all adult patients visiting the outpatient department between September 1st and October 30th, 2015. They used the Athens Insomnia Scale to diagnose insomnia and gathered data on co-morbidities in medicine. To determine the prevalence of insomnia and its associated co-morbidities, examined the data.
The China market dominated the Asia Pacific Narcolepsy Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $432.8 million by 2028.The Japan market is estimated to grow a CAGR of 10.7% during (2022 - 2028). Additionally, The India market would experience a CAGR of 12.1% during (2022 - 2028).
Based on Type, the market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy and Secondary Narcolepsy. Based on Product, the market is segmented into Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, Central Nervous System Stimulants, Tricyclic Antidepressants and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Narcolepsy Therapeutics Market is Projected to reach USD 5 Billion by 2028, at a CAGR of 10.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Jazz Pharmaceuticals plc, Shionogi & Co., Ltd., Teva Pharmaceuticals Industries Ltd., Pfizer, Inc. (Arena Pharmaceuticals, Inc.), Bioprojet, Takeda Pharmaceutical Company Limited, Ligand Pharmaceuticals, Inc., and Graymark Healthcare, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Narcolepsy with Cataplexy
- Narcolepsy Without Cataplexy
- Secondary Narcolepsy
By Product
- Sodium Oxybate
- Selective Serotonin Reuptake Inhibitor
- Central Nervous System Stimulants
- Tricyclic Antidepressants
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Jazz Pharmaceuticals plc
- Shionogi & Co., Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
- Bioprojet
- Takeda Pharmaceutical Company Limited
- Ligand Pharmaceuticals, Inc.
- Graymark Healthcare, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Narcolepsy Therapeutics Market, by Type
1.4.2 Asia Pacific Narcolepsy Therapeutics Market, by Product
1.4.3 Asia Pacific Narcolepsy Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Narcolepsy Therapeutics Market by Type
3.1 Asia Pacific Narcolepsy with Cataplexy Market by Country
3.2 Asia Pacific Narcolepsy Without Cataplexy Market by Country
3.3 Asia Pacific Secondary Narcolepsy Market by Country
Chapter 4. Asia Pacific Narcolepsy Therapeutics Market by Product
4.1 Asia Pacific Sodium Oxybate Market by Country
4.2 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country
4.3 Asia Pacific Central Nervous System Stimulants Market by Country
4.4 Asia Pacific Tricyclic Antidepressants Market by Country
4.5 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific Narcolepsy Therapeutics Market by Country
5.1 China Narcolepsy Therapeutics Market
5.1.1 China Narcolepsy Therapeutics Market by Type
5.1.2 China Narcolepsy Therapeutics Market by Product
5.2 Japan Narcolepsy Therapeutics Market
5.2.1 Japan Narcolepsy Therapeutics Market by Type
5.2.2 Japan Narcolepsy Therapeutics Market by Product
5.3 India Narcolepsy Therapeutics Market
5.3.1 India Narcolepsy Therapeutics Market by Type
5.3.2 India Narcolepsy Therapeutics Market by Product
5.4 South Korea Narcolepsy Therapeutics Market
5.4.1 South Korea Narcolepsy Therapeutics Market by Type
5.4.2 South Korea Narcolepsy Therapeutics Market by Product
5.5 Singapore Narcolepsy Therapeutics Market
5.5.1 Singapore Narcolepsy Therapeutics Market by Type
5.5.2 Singapore Narcolepsy Therapeutics Market by Product
5.6 Malaysia Narcolepsy Therapeutics Market
5.6.1 Malaysia Narcolepsy Therapeutics Market by Type
5.6.2 Malaysia Narcolepsy Therapeutics Market by Product
5.7 Rest of Asia Pacific Narcolepsy Therapeutics Market
5.7.1 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type
5.7.2 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product
Chapter 6. Company Profiles
6.1 Jazz Pharmaceuticals plc
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Approvals and Trials:
6.2 Shionogi & Co., Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Research & Development Expenses
6.3 Teva Pharmaceutical Industries Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expenses
6.4 Pfizer, Inc. (Arena Pharmaceuticals, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional & Segmental Analysis
6.4.4 Research & Development Expense
6.5 Bioprojet
6.5.1 Company Overview
6.5.2 Recent strategies and developments:
6.5.2.1 Partnerships, Collaborations, and Agreements:
6.6 Takeda Pharmaceutical Company Limited
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Ligand Pharmaceuticals, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Graymark Healthcare, Inc.
6.8.1 Company Overview
TABLE 1 Asia Pacific Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Narcolepsy with Cataplexy Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Narcolepsy with Cataplexy Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Narcolepsy Without Cataplexy Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Narcolepsy Without Cataplexy Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Secondary Narcolepsy Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Secondary Narcolepsy Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Sodium Oxybate Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Sodium Oxybate Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Selective Serotonin Reuptake Inhibitor Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Central Nervous System Stimulants Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Central Nervous System Stimulants Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Tricyclic Antidepressants Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Tricyclic Antidepressants Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Narcolepsy Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Narcolepsy Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 25 China Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 26 China Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 27 China Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 28 China Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 29 China Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 30 China Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 31 Japan Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 32 Japan Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 33 Japan Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 34 Japan Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 35 Japan Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 36 Japan Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 37 India Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 38 India Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 39 India Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 40 India Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 41 India Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 42 India Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 43 South Korea Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 44 South Korea Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 45 South Korea Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 46 South Korea Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 47 South Korea Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 48 South Korea Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 49 Singapore Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 50 Singapore Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 51 Singapore Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 52 Singapore Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 53 Singapore Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 54 Singapore Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 55 Malaysia Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 56 Malaysia Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 57 Malaysia Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 58 Malaysia Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 59 Malaysia Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 60 Malaysia Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 61 Rest of Asia Pacific Narcolepsy Therapeutics Market, 2018 - 2021, USD Million
TABLE 62 Rest of Asia Pacific Narcolepsy Therapeutics Market, 2022 - 2028, USD Million
TABLE 63 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 64 Rest of Asia Pacific Narcolepsy Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 65 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 66 Rest of Asia Pacific Narcolepsy Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 67 Key Information – Jazz Pharmaceuticals plc
TABLE 68 Key Information – Shionogi & Co., Ltd.
TABLE 69 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 70 Key Information – Pfizer, Inc.
TABLE 71 Key Information – Bioprojet
TABLE 72 Key Information – Takeda Pharmaceutical Company Limited
TABLE 73 Key Information – Ligand Pharmaceuticals, Inc.
TABLE 74 Key Information – Graymark Healthcare, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Jazz Pharmaceuticals PLC